early COVID-19 Articles
-
Smell tester for early detection of increasing Covid-19 infections
Functional principle The smell tester is measuring association velocity by using stable concentration profile of odor. Because of this the odor recognition is only dependent on the amount of available odor receptors. Changes in smell is a prominent symptom of COVID-19, as has consistently been demonstrated in many countries. By using the odor tester on patients, we could quickly detect COVID-19 ...
-
Organoid Models of SARS-CoV-2 Infection learned from COVID-19
The clinical presentation of COVID-19-related illness ranges from asymptomatic to mild respiratory symptoms resembling influenza infection to acute symptoms including pneumonia requiring hospitalization and admission to the intensive care unit. COVID-19 starts in the upper airways and lungs, but in severe cases can also affect the heart, blood vessels, brain, liver, kidneys, and intestines. ...
-
Israeli hospital pilots rapid diagnostics of blood cancer with Sight Diagnostics
Israeli-founded firm Sight Diagnostics, the company that uses AI and cutting-edge hardware to deliver rapid, complete blood count results, has signed a new research agreement with Jerusalem’s Shaare Zedek Medical Center to identify the possibility of blood cancer using a combination of images and data collected from Sight’s OLO device and patient clinical information provided by the ...
-
Sexually Transmitted Infections and Disease: The Silent Pandemic
Twenty-five years ago, the Institute of Medicine (IOM) published a report on confronting sexually transmitted diseases (STDs) as the “hidden epidemic of tremendous health and economic consequence in the United States, and that the scope, impact, and consequences of STDs are under recognized by the public and in healthcare.”1 Today, the United States is in the midst of a major ...
-
Using AI to Fight a Pandemic: Insilico Medicine Announces Novel Preclinical Candidate for COVID-19 Treatment
Insilico Medicine announced the nomination of a novel preclinical therapeutic candidate for treating COVID-19, designed using the generative chemistry AI platform Chemistry42. The new drug candidate is a 3CL protease inhibitor unique from existing drugs in its class because it can be rapidly produced. While this nomination is a potentially important development for the ongoing COVID-19 pandemic ...
-
Mic and Myra Prove Flexible and Reliable in Regional Mobile Labs
Mic qpcr cycler and Myra liquid handler have been put through their paces in COVID-19-testing field trials in regional Western Australia and found to be noticeably robust, rapidly deployable and flexible. These results have been outlined in a recent paper, Development, deployment and in-field demonstration of mobile corona virus SARS-CoV-2 Nucleic acid amplification test, published by Paton, ...
-
9 Trends that are All Set to Revolutionize Healthcare Industry Post COVID
Medical care delivery has gone through remarkable changes in the previous decade. In the last five to 10 years, medical services’ digitization has quickened dramatically because of inventive government strategies, changes in customer inclinations, a flood of funding, a developing number of computerized wellbeing business people, and proceeded with ventures by industry occupants. The ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you